Scientists at the Krembil Research Institute have developed a novel therapeutic treatment that has the potential to stop knee and spine osteoarthritis in its tracks. A team led by Principal Investigator, Arthritis Research Director at UHN, published the results today in Annals of the Rheumatic Diseases in a paper titled "microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints." "This is important because there are currently no drugs or treatments available to patients that can stop osteoarthritis," he says. Osteoarthritis is the most common form of arthritis.
It affects about five million Canadians and is characterized by a breakdown of the protective cartilage found in the body's spine, hand, knee and hip joints. "Current treatments for osteoarthritis address the symptoms, such as pain, but are unable to stop the progression of the disease," he…
